Filing Flows › Korro Bio (KRRO) › Q3 2025 › vs Q2 2025
Korro Bio (KRRO) Q3 2025 vs Q2 2025 (quarter over quarter)
Korro Bio's revenue fell $370K (-25%) from $1.5M in Q2 2025 to $1.1M in Q3 2025.
Korro Bio, Q3 2025: revenue $1.1M, net loss $18.1M, operating cash flow −$17.2M. The chart draws each line against Q2 2025, the increases inside each band.
Every line
| Line | Q3 2025 | Q2 2025 | Change | % |
|---|---|---|---|---|
| Revenue | $1.1M | $1.5M | −$370K | -25% |
| Other income, net | $1.2M | $1.4M | −$257K | -18% |
| Net loss | $18.1M | $25.8M | −$7.7M | -30% |
| Costs & expenses | $20.3M | $28.7M | −$8.3M | -29% |
| Operating costs | $20.3M | $28.7M | −$8.3M | -29% |
| Research & development | $13.8M | $20.1M | −$6.3M | -31% |
| General & admin | $6.5M | $7.3M | −$787K | -11% |
| Operating cash sources | $20.2M | $22.4M | −$2.2M | -10% |
| Depreciation | $1.2M | $1.2M | $0 | 0% |
| Share-based compensation | $1.8M | $2.0M | −$173K | -9% |
| Cash used in operations | $17.2M | $19.2M | −$2.0M | -11% |
| Net loss absorbed | $18.1M | $25.8M | −$7.7M | -30% |
| Working capital & other | $2.1M | −$3.3M | $5.5M | — |
Questions
How much did Korro Bio's revenue grow quarter over quarter in Q3 2025?
Korro Bio's revenue fell $370K (-25%) from $1.5M in Q2 2025 to $1.1M in Q3 2025.